medigraphic.com
ISSN 1608-8921 (Impreso)

2020, Número 1

<< Anterior Siguiente >>

Gaceta Médica Espirituana 2020; 22 (1)


Utilidad de la eritropoyetina en el paciente quemado grave con anemia. Revisión del tema

de la Cruz GG

Idioma: Español
Referencias bibliográficas: 30
Paginas: 60-70
Archivo PDF: 193.15 Kb.


RESUMEN

Fundamento: La quemadura grave representa el tipo de agresión biológica más severo que puede sufrir el organismo y ponen en peligro la vida del paciente por el permanente riesgo de sepsis y falla multisistémica progresiva. La anemia incide en la morbilidad y mortalidad del quemado en estado grave; su tratamiento ha pasado por diversos momentos en la historia y su corrección depende de las transfusiones sanguíneas que aumentan el riesgo de complicaciones y reacciones adversas.
Objetivo: Actualizar los conocimientos sobre la utilidad de la eritropoyetina en el tratamiento de la anemia en el quemado grave.
Desarrollo: La gravedad de la quemadura está determinada por la intensidad de la temperatura y la duración de la exposición. La anemia es una de las complicaciones más frecuentes en los quemados graves y su tratamiento en ocasiones se limita al uso de transfusiones de sangre, sin embrago la eritropoyetina es una alternativa terapéutica; pertenece a la familia de las citoquinas, alcanza la médula ósea, donde estimula células progenitoras cuyo objetivo es lograr su transformación en eritrocitos. La administración de eritropoyetina humana recombinante en el paciente quemado grave con anemia se considera eficaz, ya que al estimular los mecanismos de la eritropoyesis, produce una elevación paulatina pero mantenida del hematocrito acompañándose de otros efectos beneficiosos.
Conclusiones: La eritropoyetina humana por sus características farmacológicas, se muestra como una opción de tratamiento para el paciente quemado grave con anemia al permitir la recuperación de manera sostenida de los valores de hemoglobina con un mínimo de complicaciones, disminuye el uso de transfusiones de sangre que pueden aumentar la morbilidad de estos enfermos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Spronk I, Legemate C, Oen I, van Loey N, Polinder S, van Baar M. Health related quality of life in adults after burn injuries: A systematic review. PLoS One [Internet]. 2018 [cited 2019 Mar 24];13(5):e0197507. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967732/

  2. Tian H, Wang L, Xie W, Shen Ch, Guo G, Liu J, et al. Epidemiologic and clinical characteristics of severe burn patients: results of a severe burn patients: a retrospective multicenter study in China, 2011-2015. Burns Trauma [Internet]. 2018 [cited 2019 Mar 24];6:14. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964711/

  3. Stone R, Natesan Sh, Kowalczewski CJ, Mangun L, Clay NE, Clohessy RM, et al. Advancements in regenerative strategies through the continuum of burn care. Front Pharmacol [Internet]. 2018 [cited 2019 Mar 25];9:672. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046385/

  4. Günter CI, Machens HG, Ilg FP, Hapfelmeier A, Jelkmann W, Egert-Schwender S, et al. A randomized controlled trial: regenerative effects, efficacy and safety of erythropoietin in burn and sacaldin injuries. Front Pharmacol [Internet]. 2018 [cited 2019 Mar 25];9:951. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220439/

  5. Bang CY, Woo SH. The Fate of Chronic Burn Wounds Suspected as Marjolin's Ulcers. J Burn Care Res [Internet]. 2018 [cited 2019 Mar 25];39(1):148-53. Available from: https://academic.oup.com/jbcr/article-abstract/39/1/148/4775261?redirectedFrom=fulltext

  6. Bedri H, Romanowski KS, Liao J, Al-Ramahi G, Heard J, Granchi T, et al. A National Study of the Effect of Race, Socioeconomic Status, and Gender on Burn Outcomes. J Burn Care Res [Internet]. 2017 [cited 2019 Mar 25];38(3):161-8. Available from: https://academic.oup.com/jbcr/article-abstract/38/3/161/4582120?redirectedFrom=fulltext

  7. Spahn D, Bouillon B, Cerny V, Duranteau J, Maegele M, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Critical Care [Internet]. 2019 [cited 2019 May 6];23(1):98. Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2347-3

  8. Napolitano LM. Anemia and Red Blood Cell Transfusion. Critical care clinics. [Internet]. 2017 [cited 2019 May 6]33(2):345-64. Available from: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0749070416301233.pdf?locale=es_ES&searchIndex=

  9. Hasan S, Johnson NB, Mosier MJ, Shankar R, Conrad P, Szilagyi A, et al. Myelo-erythroid commitment after burn injury is under beta-adrenergic control via MafB regulation. Am J Physiol Cell Physiol [Internet]. 2017 [cited 2019 Mar 25];312(3):C286-C301. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401945/

  10. Austin RE, Schlagintweit S, Jeschke MG, MacDonald R, Ahghari M, Shahrokhi S. The Cost of Burn Transfers: A Retrospective Review of 7 Years of Admissions to a Regional Burn Center. J Burn Care Res [Internet]. 2018 [cited 2019 May 6];39(2):229-34. Available from: https://academic.oup.com/jbcr/article-abstract/39/2/229/4802243?redirectedFrom=fulltext

  11. Flurry MD, Herring KL, Carr LW, Hauck RM, Potochny JD. Salve and Burdock: A Safe, Effective Amish Remedy for Treatment of Traumatic Wounds? Adv Skin Wound Care [Internet]. 2017 [cited 2019 May 6];30(5):213-21. Available from: https://pennstate.pure.elsevier.com/en/publications/salve-and-burdock-a-safe-effective-amish-remedy-for-treatment-of-

  12. Gawaziuk JP, Liu T, Sigurdson L, Buchel E, Hayakawa TEJ, Shiga S, et al. Free tissue transfer for necrotizing fasciitis reconstruction: A case series. Burns [Internet]. 2017 [cited 2019 May 6];43(7):1561-6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28536044

  13. Clark A, Imran J, Madni T, Wolf SE. Nutrition and metabolism in burn patients. Burns Trauma[Internet]. 2017 [cited 2019 May 6];5:11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393025/

  14. Kraft R, Jensen KO, Jeschke MG, Schinkel CW. Patient With Scald Burn of the Esophagus. J Burn Care Res [Internet]. 2018 [cited 2019 May 6];39(3):468-70. Available from: https://academic.oup.com/jbcr/article-abstract/39/3/468/4796752?redirectedFrom=fulltext

  15. Gao G, Li W, Chen X, Liu S, Yan D, Yao X, et al. Comparing the Curative Efficacy of Different Skin Grafting Methods for Third-Degree Burn Wounds. Med Sci Monit [Internet]. 2017 [cited 2019 May 6];23:2668-73. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464767/pdf/medscimonit-23-2668.pdf

  16. Saied N, Harfoush A, Ayed T, Moustafa A, Hassan R, Eldolify E, et al. Team Approach Helps Patient Survive High-voltage Electric Burn. Plast Reconstr Surg Glob Open [Internet]. 2017 [cited 2019 May 6];5(3):e1243. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404433/

  17. Xu P, Fu X, Xiao N, Guo Y, Pei Q, Peng Y, et al. Involvements of gamma delta T Lymphocytes in Acute and Chronic Skin Wound Repair. Inflammation [Internet]. 2017 [cited 2019 May 6];40(4):1416-27. Available from: https://link.springer.com/article/10.1007%2Fs10753-017-0585-6

  18. Rehou S, Mason S, MacDonald J, Pinto R, Jeschke MG. The influence of substance misuse on clinical outcomes following burn. Burns [Internet]. 2017 [cited 2019 May 6];43(7):1493-8. Available from: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0305417917302073.pdf?locale=es_ES&searchIndex=

  19. Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R. Efecto de la Administración de Eritropoyetina Recombinante Humana (EPOrHu) en los Niveles Séricos del Receptor Soluble de Transferrina (RST) y en el Rendimiento en Ciclismo. PubliCE [Internet]. 2015 [citado 3 Jun 2019]; [aprox 10.p]. Disponible en: https://journal.onlineeducation.center/api-oas/v1/articles/sa-E57cfb272497fd/export-pdf

  20. Holbro A, Skoda R, Lundberg P, Passweg J, Buser A, Lehmann T. Erythropoietin receptor mutation—a rush of blood to the head? Ann Hematol [Internet]. 2015 [cited 2019 May 6];94(7):1229-31. Available from: https://link.springer.com/article/10.1007%2Fs00277-015-2346-7

  21. Luzardo Iglesias B, Castillo Calderón GJ, Pina Morales E, García García I, Espinosa Machado BM. Eficacia de la aplicación de la eritropoyetina humana recombinante en el tratamiento de la anemia del paciente quemado. Mediciego [Internet]. 2013 [citado 3 Jun 2019];19(1):[aprox 6.p]. Disponible en: https://www.medigraphic.com/pdfs/mediciego/mdc-2013/mdc131f.pdf

  22. Murillo AU, Barrantes CF. Importancia de la Biotecnología en el desarrollo de medicamentos. Revistas UCR [Internet]. 2015 [citado 3 Jun 2019];5(5):1-7. Disponible en: https://revistas.ucr.ac.cr/index.php/clinica/article/view/20780/20925

  23. Williams KN, Szilagyi A, Conrad P, Halerz M, Kini AR, Li Y, et al. Peripheral blood mononuclear cell-derived erythroid progenitors and erythroblasts are decreased in burn patients. J Burn Care Res [Internet]. 2013 [cited 2019 May 6];34(1):133-41. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23292581

  24. Kiang JG, Zhai M, Liao PJ, Bolduc DL, Elliott TB, Gorbunov NV. Pegylated G-CSF inhibits blood cell depletion, increases platelets, blocks splenomegaly, and improves survival after whole-body ionizing irradiation but not after irradiation combined with burn. Oxidative med. cell. longev. [Internet]. 2014 [cited 2019 May 6];2014. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964894/

  25. Era T, Takagi T, Takahashi T, Bories JC, Nakano T. Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system. Blood [Internet]. 2000[cited 2019 May 6];95(3):870-8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10648398

  26. Pérez-Oliva Díaz JF. 15 años de Eritropoyetina Recombinante Humana cubana. Beneficios y retos. Rev haban cienc méd [Internet]. 2013 [citado 3 Jun 2019];12(3):464-71. Disponible en: http://scielo.sld.cu/pdf/rhcm/v12n3/rhcm19313.pdf

  27. Pérez-Oliva Díaz JF, Casanova González M, Cuesta Panaco O, Bencomo Rodríguez O, López Tórres B, González C, et al. Tratamiento con eritropoyetina recombinante humana, hipertrofia ventricular izquierda y balance beneficio riesgo en la ERC-3b. Rev haban cienc méd [Internet]. 2013 [citado 3 Jun 2019];12(3):472-86. Disponible en: http://scielo.sld.cu/pdf/rhcm/v12n3/rhcm20313.pdf

  28. Hu DH, Tao K. To see the future development of burn medicine from the view of holistic integrative medicine. Zhonghua Shao Shang Za Zhi [Internet]. 2017 [cited 2019 May 6];33(4):193-5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28427130

  29. Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, et al. Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. Am Surg [Internet]. 2010 [cited 2019 May 6];76(9):951-6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20836341

  30. Huang GS, Dunham CM. Mortality outcomes in trauma patients undergoing prehospital red blood cell transfusion: a systematic literature review. Int J Burns Trauma [Internet]. 2017 [cited 2019 May 6];7(2):17-26. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435648/




2020     |     www.medigraphic.com